Enliven Therapeutics shares owned by Legal & General Group
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Legal & General Group
from 13F filings
Historical chart of Legal & General Group investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Enliven Therapeutics by Legal & General Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $691k | 34k | 20.47 |
| 2025-06-30 | $646k | 32k | 20.06 |
| 2025-03-31 | $417k | 21k | 19.69 |
| 2024-12-31 | $476k | 21k | 22.50 |
| 2024-09-30 | $519k | 20k | 25.55 |
| 2024-06-30 | $472k | 20k | 23.37 |
| 2024-03-31 | $364k | 21k | 17.64 |
| 2023-12-31 | $272k | 20k | 13.84 |
| 2023-09-30 | $269k | 20k | 13.66 |
| 2023-06-30 | $369k | 18k | 20.41 |